SnipsRecapsAboutFAQ
Health

Lilly says its popular weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients.

SOURCES
Mastodon5
News4
  • Jun 23
    @yahoousnewsrss@newsmast.social
    Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea #breakingnews#news
  • Jun 22
    Slashdot.org
    • feedfeeder
    Mounjaro Drug Tirzepatide Could Treat Sleep Apnea, Study Finds - Forbes
  • Jun 21
    @thenewyorktimesrss@newsmast.social
    Weight-Loss Drug Zepbound Offers a New Way to Treat Sleep Apnea #breakingnews#news
  • Jun 21
    @PressNewsAgency@mastodon.social
    Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year Also on Friday, the company released additional data from two late-stage trials showing that Zepbound helped resolve obstructive sleep apnea, or OSA, in almost half of patients. Eli Lilly presented the new data from the trials at the American Diabetes Association's 84th Scientific Sessions in Orlando, Florida, on Friday. "We're super excited. … I think it actually…
  • Jun 21
    Forbes
    • Robert Hart, Fo...
    Mounjaro Drug Tirzepatide Could Treat Sleep Apnea, Study Finds